ChronoScale director Scott Davis resigns after Ekso sale; gets $709,500 and 51,626 RSUs

EKSO BIONICS HOLDINGS, INC.

Scott Davis, Ekso Bionics CEO and ChronoScale board member, resigned from the board effective October 3, 2026, with no disagreements cited; the Ekso sale closed September 30, 2026.
Davis received 51,626 fully vested restricted stock units granted October 2, 2026, plus a $709,500 lump-sum cash payment payable within 30 days under a Release Agreement.
The Release Agreement includes a general release of claims and stands in lieu of any payment under the Nov. 5, 2025 Change in Control and Severance Agreement; the Phantom RSU Agreement is unchanged.
ChronoScale common stock trades on the Nasdaq Capital Market under CHRN; CFO Jerome Wong signed the report dated October 6, 2026.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Scott Davis

Member of the Board of Directors

CHRN · EKSO BIONICS HOLDINGS, INC.

Effective: 2026-10-03
Filed: October 6, 2026, 5:20 PM ET

Scott Davis, a member of the Board of Directors of the Company (the “Board”) and Chief Executive Officer (“CEO”) of Ekso, resigned from his position as a member of the Board, effective as of October 3, 2026. There were no disagreements between the Company and Mr. Davis that led to his decision to resign.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Scott Davis resigned as Member of the Board of Directors at EKSO BIONICS HOLDINGS, INC..

Action: resigned
Role: Member of the Board of Directors

Exact text from the filing

Scott Davis, a member of the Board of Directors of the Company (the “Board”) and Chief Executive Officer (“CEO”) of Ekso, resigned from his position as a member of the Board, effective as of October 3, 2026. There were no disagreements between the Company and Mr. Davis that led to his decision to resign.

View on SEC.gov

EKSO BIONICS HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001493152-26-046010

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.